Alex Froimovich

Dr. Alex Froimovich joins CathWorks with over 18 years of experience in the medical device industry. Dr. Froimovich has been integral to the development, commercialization, and evidence development of multiple lifesaving and life-changing innovative technologies globally, including the first drug-eluting stent, the market-leading transcatheter heart valve, and the most advanced deep brain stimulator. Dr. Froimovich brings a long track record in medical affairs and scientific communications successes at some of the leading medical device manufacturers such as Johnson & Johnson, Edwards Lifesciences, and Boston Scientific.

He earned his M.D. from the Pontificia Universidad Católica de Chile and his M.B.A. from Rutgers Business School.